Clinical trial

Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel

NCT03082573

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-03-03

PhasePHASE4

Study timeline

Study start (actual)2017-03-03Date precision: day

Registry last updated2017-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

H.P. Acthar gelDRUG

Sponsors & collaborators

Iraj Sabahi Research Inc.lead sponsor

Mallinckrodtcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03082573 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.